Triple
T19376786
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | He Jiankui |
E484689
|
entity |
| Predicate | editedGene |
P126444
|
FINISHED |
| Object | CCR5 |
—
|
NE NERFINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CCR5 | Statement: [He Jiankui, editedGene, CCR5]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CCR5 Context triple: [He Jiankui, editedGene, CCR5]
-
A.
CD22
CD22 is a B-cell–specific surface glycoprotein that functions as an inhibitory co-receptor modulating B cell receptor signaling and immune responses.
-
B.
CD21
CD21 is a complement receptor (CR2) found on B cells and follicular dendritic cells that plays a key role in B cell activation and the immune response.
-
C.
CD46
CD46 is a human cell-surface complement regulatory protein that also serves as an entry receptor for various pathogens, including certain adenoviruses and measles virus.
-
D.
CD19
CD19 is a B-cell surface protein widely used as a key immunotherapy target in treatments for B-cell malignancies such as certain leukemias and lymphomas.
-
E.
ACE2
ACE2 is a human cell-surface enzyme and receptor that plays a key role in regulating blood pressure and serves as the primary entry point for SARS-CoV-2 into host cells.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CCR5 Target entity description: CCR5 is a human cell-surface chemokine receptor best known as a key co-receptor for HIV entry into immune cells and as a target for both natural resistance and gene-editing interventions against HIV infection.
-
A.
CD22
CD22 is a B-cell–specific surface glycoprotein that functions as an inhibitory co-receptor modulating B cell receptor signaling and immune responses.
-
B.
CD21
CD21 is a complement receptor (CR2) found on B cells and follicular dendritic cells that plays a key role in B cell activation and the immune response.
-
C.
CD46
CD46 is a human cell-surface complement regulatory protein that also serves as an entry receptor for various pathogens, including certain adenoviruses and measles virus.
-
D.
CD19
CD19 is a B-cell surface protein widely used as a key immunotherapy target in treatments for B-cell malignancies such as certain leukemias and lymphomas.
-
E.
ACE2
ACE2 is a human cell-surface enzyme and receptor that plays a key role in regulating blood pressure and serves as the primary entry point for SARS-CoV-2 into host cells.
- F. None of above. chosen
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: editedGene Context triple: [He Jiankui, editedGene, CCR5]
-
A.
geneEditingMethod
Indicates a method or technique used to modify or edit the genetic material of an organism.
-
B.
geneticallyManipulatedBy
chosen
Indicates that an entity’s genetic material has been altered or modified as a result of actions performed by another specified agent or process.
-
C.
editedIn
Indicates that an entity was modified, revised, or otherwise altered within a particular context, tool, environment, or time frame.
-
D.
editedLanguage
Indicates that one entity has revised, modified, or otherwise edited the language or linguistic content of another entity.
-
E.
geneticElement
Indicates that one entity is a genetic element (such as a gene, sequence, or structural unit of genetic material) associated with or characterized by the other entity.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8e8d460d88190abf0591c5c9d2b0c |
completed | April 10, 2026, 12:11 p.m. |
| NER | Named-entity recognition | batch_69e61a5cfbf48190ac60e3ffa6baa263 |
completed | April 20, 2026, 12:21 p.m. |
| PD | Predicate disambiguation | batch_69e4fd54f8e48190956e73dd8969164a |
completed | April 19, 2026, 4:05 p.m. |
Created at: April 10, 2026, 1:35 p.m.